RolandWolf

[TimAlerts] ADAP Adaptimmune Therapeutics announces that the FDA has removed the partial clinical hold on the planned study of its NYESO SPEAR T-cell therapy in MRCLS --shares halted-- ADAP 

kevinmullinax

[TimChallenge] Michael - can I ask your thoughts on ADAP? It had a MACD crossover today and is well below the 20-day EMA. Three green candles in a row.

CheezWhiz

[TimAlerts] ADAP. Contract winner. Big spike PM. Up 136%. Still in study mode but watchlisting it

willmiller42

[SuperAlerts] ADAP Adaptimmune Receives Access to Priority Medicines (PRIME) Regulatory Support for its SPEAR® T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma

gtucker8585

[TimAlerts] ADAP - Adaptimmune Announces Commercial Development and Supply Agreement for Thermo Fisher Scientific's Dynabeads(TM) CD3/CD28 Cell Therapy System

Page
of 5